These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1146 related articles for article (PubMed ID: 33956939)

  • 1. Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated With Increased Coronavirus Disease 2019 (COVID-19) Risk in a Population-Based Cohort Study.
    Nicolete VC; Rodrigues PT; Johansen IC; Corder RM; Tonini J; Cardoso MA; de Jesus JG; Claro IM; Faria NR; Sabino EC; Castro MC; Ferreira MU
    Clin Infect Dis; 2021 Dec; 73(11):2045-2054. PubMed ID: 33956939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seropositivity and COVID-19 among 5 years-old Amazonian children and their association with poverty and food insecurity.
    Ferreira MU; Giacomini I; Sato PM; Lourenço BH; Nicolete VC; Buss LF; Matijasevich A; Castro MC; Cardoso MA;
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010580. PubMed ID: 35849564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.
    Cheng YL; Chao CH; Lai YC; Hsieh KH; Wang JR; Wan SW; Huang HJ; Chuang YC; Chuang WJ; Yeh TM
    Front Immunol; 2022; 13():941923. PubMed ID: 36045680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of COVID-19 in a Dengue-Endemic Area.
    Lokida D; Lukman N; Salim G; Butar-Butar DP; Kosasih H; Wulan WN; Naysilla AM; Djajady Y; Sari RA; Arlinda D; Lau CY; Karyana M
    Am J Trop Med Hyg; 2020 Sep; 103(3):1220-1222. PubMed ID: 32762798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: A cohort study in a SARS-CoV-2 testing center on Reunion island.
    Joubert A; Andry F; Bertolotti A; Accot F; Koumar Y; Legrand F; Poubeau P; Manaquin R; Gérardin P; Levin C
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0008879. PubMed ID: 33901185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
    Fofana MO; Nery N; Aguilar Ticona JP; de Andrade Belitardo EMM; Victoriano R; Anjos RO; Portilho MM; de Santana MC; Dos Santos LL; de Oliveira D; Cruz JS; Muenker MC; Khouri R; Wunder EA; Hitchings MDT; Johnson O; Reis MG; Ribeiro GS; Cummings DAT; Costa F; Ko AI
    PLoS Med; 2022 Sep; 19(9):e1004093. PubMed ID: 36074784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses.
    Lustig Y; Keler S; Kolodny R; Ben-Tal N; Atias-Varon D; Shlush E; Gerlic M; Munitz A; Doolman R; Asraf K; Shlush LI; Vivante A
    Clin Infect Dis; 2021 Oct; 73(7):e2444-e2449. PubMed ID: 32797228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge.
    Bicudo N; Bicudo E; Costa JD; Castro JALP; Barra GB
    Braz J Infect Dis; 2020; 24(5):452-454. PubMed ID: 32866435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses.
    Stringari LL; de Souza MN; de Medeiros Junior NF; Goulart JP; Giuberti C; Dietze R; Ribeiro-Rodrigues R
    PLoS One; 2021; 16(1):e0244937. PubMed ID: 33406122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of concurrent epidemics of dengue, chikungunya, zika, and COVID-19.
    Vicente CR; Silva TCCD; Pereira LD; Miranda AE
    Rev Soc Bras Med Trop; 2021; 54():e08372020. PubMed ID: 33656154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Infection between Dengue Virus and SARS-CoV-2 in Cali, Colombia.
    Agudelo-Rojas OL; Rebellón-Sánchez DE; Llanos Torres J; Zapata-Vásquez IL; Rodríguez S; Robles-Castillo S; Tejada Vega A; Parra-Lara LG; Rosso F
    Am J Trop Med Hyg; 2023 Sep; 109(3):536-541. PubMed ID: 37580025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.
    Maver Vodičar P; Oštrbenk Valenčak A; Zupan B; Avšič Županc T; Kurdija S; Korva M; Petrovec M; Demšar J; Knap N; Štrumbelj E; Vehovar V; Poljak M
    Clin Microbiol Infect; 2020 Nov; 26(11):1514-1519. PubMed ID: 32688068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Recent Prior Dengue Infection on Risk and Severity of Subsequent SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Tang N; Lim JT; Dickens B; Chiew C; Ng LC; Chia PY; Leo YS; Lye DC; Tan KB; Wee LE
    Open Forum Infect Dis; 2024 Aug; 11(8):ofae397. PubMed ID: 39091642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.